84 related articles for article (PubMed ID: 17408061)
21. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
22. Synergistic induction of monocyte chemoattractant protein-1 by integrins and platelet-derived growth factor via focal adhesion kinase in mesangial cells.
Kanegae K; Tamura M; Kabashima N; Serino R; Tokunaga M; Oikawa S; Nakashima Y
Nephrol Dial Transplant; 2005 Oct; 20(10):2080-8. PubMed ID: 16030037
[TBL] [Abstract][Full Text] [Related]
23. Blockade by nifedipine of advanced glycation end product-induced CD40-CD40 ligand interaction in endothelial cells.
Yamagishi S; Kikuchi S; Takenaka K; Takeuchi M
Drugs Exp Clin Res; 2005; 31(5-6):221-6. PubMed ID: 16425979
[TBL] [Abstract][Full Text] [Related]
24. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
25. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
26. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
27. Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells.
Matsui T; Yamagishi S; Nakamura K; Inoue H
J Int Med Res; 2006; 34(6):671-5. PubMed ID: 17295000
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells.
Janssen U; Sowa E; Marchand P; Floege J; Phillips AO; Radeke HH
Nephron; 2002 Dec; 92(4):797-806. PubMed ID: 12399623
[TBL] [Abstract][Full Text] [Related]
29. Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells.
Watanabe Y; Tamura M; Osajima A; Anai H; Kabashima N; Serino R; Nakashima Y
Kidney Int; 2003 Aug; 64(2):431-40. PubMed ID: 12846738
[TBL] [Abstract][Full Text] [Related]
30. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells.
Ruiz-Ortega M; Lorenzo O; Egido J
Kidney Int; 2000 Jun; 57(6):2285-98. PubMed ID: 10844599
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
33. Adrenomedullin inhibits pressure-induced mesangial MCP-1 expression through activation of protein kinase A.
Iwamoto M; Osajima A; Tamura M; Suda T; Ota T; Kanegae K; Watanabe Y; Kabashima N; Anai H; Nakashima Y
J Nephrol; 2003; 16(5):673-81. PubMed ID: 14733413
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Ohta MY; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2000 Feb; 49(2):163-6. PubMed ID: 10690939
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of monocyte chemoattractant protein-1 expression via inhibition of nuclear factor-kappaB activity in inflammatory vascular injury.
Gao X; Iwai M; Inaba S; Tomono Y; Kanno H; Mogi M; Horiuchi M
Am J Hypertens; 2007 Nov; 20(11):1170-5. PubMed ID: 17954363
[TBL] [Abstract][Full Text] [Related]
36. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
Banba N; Nakamura T; Matsumura M; Kuroda H; Hattori Y; Kasai K
Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
[TBL] [Abstract][Full Text] [Related]
39. Monocyte chemoattractant protein (MCP)-1 production via functionally reconstituted Fcalpha receptor (CD89) on glomerular mesangial cells.
Tsuge T; Suzuki Y; Shimokawa T; Horikoshi S; Okumura K; Ra C; Tomino Y
Inflamm Res; 2003 Oct; 52(10):428-32. PubMed ID: 14520519
[TBL] [Abstract][Full Text] [Related]
40. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin.
Kim SY; Guijarro C; O'Donnell MP; Kasiske BL; Kim Y; Keane WF
Kidney Int; 1995 Aug; 48(2):363-71. PubMed ID: 7564103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
